Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) have received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $13.00.

Several research firms have recently issued reports on CURLF. Atb Cap Markets reaffirmed an “outperform” rating on shares of Curaleaf in a report on Tuesday, July 4th. Stifel Nicolaus reduced their target price on Curaleaf from C$3.50 to C$3.00 in a report on Friday, August 11th. Benchmark lowered Curaleaf from a “buy” rating to a “hold” rating in a report on Friday, May 19th. ATB Capital began coverage on Curaleaf in a report on Wednesday, July 5th. They issued an “outperform” rating for the company. Finally, Needham & Company LLC reissued a “buy” rating and set a $4.25 price objective on shares of Curaleaf in a report on Thursday, August 10th.

Curaleaf Stock Performance

Shares of CURLF opened at $5.39 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.42 and a current ratio of 0.90. The stock has a 50 day moving average price of $3.55 and a two-hundred day moving average price of $3.15. The firm has a market capitalization of $3.40 billion and a P/E ratio of -8.98. Curaleaf has a 52 week low of $2.19 and a 52 week high of $7.90.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, August 9th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.03). The company had revenue of $338.58 million for the quarter, compared to the consensus estimate of $339.02 million. Curaleaf had a negative return on equity of 23.38% and a negative net margin of 31.99%. Equities analysts forecast that Curaleaf will post -0.24 earnings per share for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.